Track NeuroMetrix, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

NeuroMetrix, Inc. NURO · Stock Open NeuroMetrix, Inc. in new tab

4.58 USD
ROE
-45.38
Beta
1.84
Loading chart...
Key Metrics
Debt/Equity0.75
% Insiders22.552%
Growth
Revenue Growth-0.56%

DCF valuation

Model fair value for NeuroMetrix, Inc. (NURO)
Result
Sign in to run the valuation for NURO.
Assumptions
Growth– Capex– Tax– Terminal g– Cost of equity– Cost of debt–

NeuroMetrix, Inc. Logo NeuroMetrix, Inc. Analysis (NURO)

United States Health Care Official Website Stock

Is NeuroMetrix, Inc. a good investment? NeuroMetrix, Inc. (NURO) is currently trading at 4.58 USD.

Investor FAQ

Does NeuroMetrix, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is NeuroMetrix, Inc.?

NeuroMetrix, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

Company Profile

NeuroMetrix, Inc., a commercial stage neurotechnology company, engages in designing and sale of medical devices. Its marketed products include DPNCheck, a nerve conduction test that is used to evaluate peripheral neuropathies, such as diabetic peripheral neuropathy; and Quell, a wearable device for symptomatic relief and management of chronic pain. The company offers its products to managed endocrinologists, podiatrists, primary care physicians, and other clinicians at the point-of care to objectively detect, stage, and monitor peripheral neuropathies. NeuroMetrix, Inc. was incorporated in 1996 and is headquartered in Woburn, Massachusetts.

Exchange Ticker
NMS (United States) NURO
Trades
Dividend History paid per year (USD)
Historical Dividends
Year Total Dividends
▸2007
0.15 USD
April 13, 2007 0.1500
Stock Splits
Split Date Split Ratio to 1
Sept. 2, 2011 0.17
Feb. 19, 2013 0.17
Dec. 2, 2015 1:4
May 12, 2017 0.12
Nov. 19, 2019 1:10
Nov. 22, 2023 0.12
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion